Charles River Acquires Cerebricon LTD
August 4, 2009 – Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Cerebricon Ltd. Cerebricon, located in Kuopio, Finland, brings together MRI (magnetic resonance imaging) techniques, biomarkers and behavioral measurements in gold standard assays for acute neurology (such as stroke and spinal cord injury), chronic neurology (including multiple sclerosis and Alzheimer’s and Parkinson’s disease) and psychiatry (exemplified by ADHD, schizophrenia and depression).
Through our Discovery and Imaging Services group, which includes MIR Preclinical Services (acquired in 2008) and Piedmont Research Center (acquired in 2009), we have established ourselves as a premier provider of non-GLP pharmacology and in vivo imaging services for the evaluation of compound efficacy. Our therapeutic areas of expertise now span oncology, cardiovascular, metabolism, inflammation and CNS, all of which are areas of increasing R&D focus.
For more information, please call 800.3195.3430 or email us at email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Selecting the appropriate animal model for your studies is critical to the success of your research. This is why, in 2011, our Model Evaluation Program was created to offer researchers a risk-free opportunity to evaluate the quality of our animal models prior to allocating valuable budget money or study resources.
Now, to further support your research needs, we have expanded our program to include the option to evaluate both surgically altered models and rodent biospecimen products
Charles River offers animal models with combined surgeries or services (e.g., feeding studies with tissue collection) to help meet the dynamic needs of our customers.
juin 10–juin 13
Visit us in booth #091 to learn more about our recent innovations including expanded diagnostic capabilities, a new online portal connecting clients with their colonies and a deep-rooted commitment to humane care.
mai 21–mai 24
RDD Europe 2013 is a forum for pulmonary and nasal drug delivery experts from all around the world to exchange scientific knowledge and expertise.
mai 23–mai 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
Charles River Laboratories, Inc.